Keyword Search Year None2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 Date Title 04/24/2024 Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 04/11/2024 Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City 03/28/2024 Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference 03/12/2024 Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates 02/28/2024 Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024 01/23/2024 Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures 01/07/2024 Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain